Literature DB >> 20736801

Local antibiotic delivery using tailorable chitosan sponges: the future of infection control?

Daniel J Stinner1, Scott P Noel, Warren O Haggard, J Tracy Watson, Joseph C Wenke.   

Abstract

OBJECTIVES: Local antibiotic delivery is a viable and attractive option for preventing infection. Unfortunately, the current options are limited and often necessitate surgical removal. This study evaluates the ability of a biodegradable and biocompatible chitosan sponge to minimize infection by delivering local antibiotics within the wound.
METHODS: A complex musculoskeletal wound was created on the hindlimb of goats and contaminated with Pseudomonas aeruginosa (lux) or Staphylococcus aureus (lux) bacteria. These bacteria are genetically engineered to emit photons, allowing for quantification with a photon-counting camera system. The wounds were closed and similarly débrided and irrigated with 9 L normal saline using bulb-syringe irrigation 6 hours after inoculation. Goats were assigned to different treatment groups: a control group with no adjunctive treatment and an experimental group using a chitosan sponge loaded with either amikacin (for wounds contaminated with P. aeruginosa) or vancomycin (for wounds contaminated with S. aureus). The wounds were closed after the procedure and evaluated 48 hours after initial contamination. Serum levels of the antibiotics were also measured at 6, 12, 24, 36, and 42 hours after treatment was initiated.
RESULTS: The wounds treated with the antibiotic-loaded chitosan sponge had significantly less bacteria than the untreated wounds (P < 0.05). The highest serum levels were 6 hours after treatment but remained less than 15% of target serum levels for systemic treatment. At study end point, all sponges were between 60% and 100% degraded.
CONCLUSIONS: The chitosan sponges are effective delivering the antibiotic and reducing the bacteria within the wounds.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20736801     DOI: 10.1097/BOT.0b013e3181ed296c

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  16 in total

Review 1.  [Prevention of infection in the current treatment of open fractures: an evidence-based systematic analysis].

Authors:  S Grote; H Polzer; W C Prall; S Gill; S Shafizadeh; M Banerjee; B Bouillon; H Bäthis
Journal:  Orthopade       Date:  2012-01       Impact factor: 1.087

2.  Chitosan coating to enhance the therapeutic efficacy of calcium sulfate-based antibiotic therapy in the treatment of chronic osteomyelitis.

Authors:  Karen E Beenken; James K Smith; Robert A Skinner; Sandra G Mclaren; William Bellamy; M Johannes Gruenwald; Horace J Spencer; Jessica A Jennings; Warren O Haggard; Mark S Smeltzer
Journal:  J Biomater Appl       Date:  2014-05-21       Impact factor: 2.646

3.  Novel Antimicrobial Peptides Formulated in Chitosan Matrices are Effective Against Biofilms of Multidrug-Resistant Wound Pathogens.

Authors:  Jennifer A Neff; Danir F Bayramov; Esha A Patel; Jing Miao
Journal:  Mil Med       Date:  2020-01-07       Impact factor: 1.437

4.  Novel Antibiotic-loaded Point-of-care Implant Coating Inhibits Biofilm.

Authors:  Jessica Amber Jennings; Daniel P Carpenter; Karen S Troxel; Karen E Beenken; Mark S Smeltzer; Harry S Courtney; Warren O Haggard
Journal:  Clin Orthop Relat Res       Date:  2015-07       Impact factor: 4.176

5.  Blended Chitosan Paste for Infection Prevention: Preliminary and Preclinical Evaluations.

Authors:  Joel M Berretta; Jessica A Jennings; Harry S Courtney; Karen E Beenken; Mark S Smeltzer; Warren O Haggard
Journal:  Clin Orthop Relat Res       Date:  2017-07       Impact factor: 4.176

6.  Chitosan sponges for local synergistic infection therapy: a pilot study.

Authors:  J Keaton Smith; Abteen R Moshref; Jessica A Jennings; Harry S Courtney; Warren O Haggard
Journal:  Clin Orthop Relat Res       Date:  2013-04-20       Impact factor: 4.176

7.  Biochemical and Biophysical Cues in Matrix Design for Chronic and Diabetic Wound Treatment.

Authors:  Yun Xiao; Samad Ahadian; Milica Radisic
Journal:  Tissue Eng Part B Rev       Date:  2016-08-19       Impact factor: 6.389

Review 8.  Biomaterials approaches to treating implant-associated osteomyelitis.

Authors:  Jason A Inzana; Edward M Schwarz; Stephen L Kates; Hani A Awad
Journal:  Biomaterials       Date:  2015-12-18       Impact factor: 12.479

Review 9.  Infection and tissue engineering in segmental bone defects--a mini review.

Authors:  Manitha B Nair; James D Kretlow; Antonios G Mikos; F Kurtis Kasper
Journal:  Curr Opin Biotechnol       Date:  2011-02-25       Impact factor: 9.740

10.  Cis-2-decenoic acid inhibits S. aureus growth and biofilm in vitro: a pilot study.

Authors:  Jessica Amber Jennings; Harry S Courtney; Warren O Haggard
Journal:  Clin Orthop Relat Res       Date:  2012-10       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.